Tag: IP

Ignoring Moisture Sensitivity During Scale-Up: Meeting Compatibility Study Expectations In pharmaceutical manufacturing, overlooking moisture sensitivity during scale-up can lead to significant product failures, batch discrepancies, and regulatory scrutiny. The inability…

Addressing Functional Performance Failures in Formulation Development through CAPA In the complex world of pharmaceutical formulation development, functional performance failures can significantly impede progress, leading to delays and increased costs.…

Assessing Supplier Grade Substitution during Stability Studies: An Investigation Approach In the realm of pharmaceutical manufacturing, the integrity of raw materials is paramount, especially regarding excipients utilized in stability assessments.…

Assessing Risks from Suboptimal Excipient Selection During Supplier Qualification In the context of pharmaceutical manufacturing, the selection of excipients plays a critical role in ensuring the safety, efficacy, and quality…

Addressing Improper Excipient Selection to Avert Late-Stage Reformulation Issues In pharmaceutical development, the choice of excipient is critical to the success of a formulation. However, unjustified excipient choices can lead…

Exploring the Investigation Process for Functional Performance Failures in Supplier Qualification In the pharmaceutical manufacturing industry, ensuring the quality and compatibility of raw materials, especially excipients, is paramount. Functional performance…

Overlooking Moisture Sensitivity in Stability Assessments: An Investigation Framework In the pharmaceutical manufacturing landscape, ensuring the quality and stability of both active pharmaceutical ingredients (APIs) and excipients is paramount. A…

Addressing Moisture Sensitivity Issues During Scale-Up to Avoid Late-Stage Reformulation In pharmaceutical manufacturing, the transition from small-scale to full-scale production is critical, yet it can expose previously unnoticed issues related…

Assessing Variability in Excipient Grades During Regulatory Review Variability in excipient grade during regulatory review can pose significant challenges for pharmaceutical companies, impacting both the approval process and product quality.…